Bullish
KLRS Initiates Coverage On by TD Cowen -- Rating Set to Buy
TD Cowen has initiated coverage on Kalaris Therapeutics (KLRS) with a Buy rating, noting the company's focus on developing therapeutics for retinal di...
KLRS
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest KLRS News
Research KLRS on:
Ad Space